naturalX Health Ventures has announced a €100 million fund to accelerate consumer-centred healthcare in Europe, becoming the first specialised fund focused exclusively on the intersection of consumer and health in the European market.
The fund will focus primarily on Series-A investments while remaining flexible to participate in late Seed and Series-B rounds.
Typical first investments range from €3-5 million, with up to €10 million available per company.
naturalX can act as either lead investor or co-investor, targeting consumer health startups across Europe with selected investments in North America.
naturalX was founded by Marvin Amberg, a German serial entrepreneur with experience launching consumer and health startups, in cooperation with Schwabe Group, a global leader in plant-based pharmaceuticals.
The fund defines consumer health as the intersection of wellness and medicine, where science-backed products and services put the consumer in focus.
During its 18-month ramp-up phase, naturalX has already made several investments, including mybacs, Flow Neuroscience, Kyan Health, and Meela, while also investing in healthcare-focused VC funds to build a strong ecosystem around their thesis.
Amberg said: “I am very excited to double down on our thesis with the official launch of naturalX.
“The consumer health space has been overlooked by investors.
We see an inflection point in Europe now, as consumers are finally taking more charge of their own health.
“Startups in the space need a partner with a shared vision.”
The fund’s launch comes at a pivotal moment in consumer health.
The COVID-19 pandemic has accelerated consumers focus on proactive health management, while rising health literacy – driven by mega-influencers like Andrew Huberman, Peter Attia and Bryan Johnson – has created more informed healthcare consumers who see health as a status symbol.
Easier access to data through technology, including AI, is further driving the shift toward consumer-centric healthcare.
naturalX targets solutions across proactive health, including sleep, gut health, prevention and longevity.
The fund also places special emphasis on mental health, recognising the growing need for consumer-centric therapeutic solutions in this underserved area.
